No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Feb 2023.
Get an email when SPRB's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Parkman Healthcare Partners LLC Large holder | SoldNo plan 2 parts | 257 | $19.15 average | 5K | 20% | Form 4 |
| Oct 6, 2025 | Parkman Healthcare Partners LLC Large holder | Bought | 256 | $17.91 | 5K | 32% | Form 4 |
| Oct 6, 2025 | Parkman Healthcare Partners LLC Large holder | SoldNo plan 2 parts | 257 | $19.15 average | 5K | 20% | Form 4 |
| Oct 6, 2025 | Parkman Healthcare Partners LLC Large holder | Bought | 256 | $17.91 | 5K | 32% | Form 4 |
- Oct 6, 2025No planParkman Healthcare Partners LLCLarge holder · sold 257 at avg $19.155K20% of stake
- Oct 6, 2025Parkman Healthcare Partners LLCLarge holder · bought 256 at $17.915K32% of stake
- Oct 6, 2025No planParkman Healthcare Partners LLCLarge holder · sold 257 at avg $19.155K20% of stake
- Oct 6, 2025Parkman Healthcare Partners LLCLarge holder · bought 256 at $17.915K32% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with SPRB
Held by ETFs
SPRB is in 2 US ETFs. The largest of them, with SPRB's weight in each:
Spot a number that looks wrong? Check it in SPRB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SPRB
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.